Scientists grow human brains in space to treat Alzheimer's
Microgravity facilitates rapid growth of brain organoids, enabling critical research into treatments for Alzheimer's, Parkinson's, and spinal injuries.
In other news this week: Knave secures 225M, London-based Purespring raises 95M, VERBUND X Ventures invests in Ausrtia's Easelink, and more - Silicon Canals
Tech innovations in October highlighted significant funding rounds for companies like Knave, Purespring, and Basecamp Research.
Swiss startup creates modular device for on-demand cell therapy manufacturing
Automated cell therapy manufacturing with less stress and contamination through modular device.
In other news this week: Knave secures 225M, London-based Purespring raises 95M, VERBUND X Ventures invests in Ausrtia's Easelink, and more - Silicon Canals
Tech innovations in October highlighted significant funding rounds for companies like Knave, Purespring, and Basecamp Research.
Swiss startup creates modular device for on-demand cell therapy manufacturing
Automated cell therapy manufacturing with less stress and contamination through modular device.
Trinity College Dublin scientists make breakthrough on gene therapy for eye disease described as 'silent thief of sight'
Gene therapy shows promise in protecting vision by improving retinal cell function in glaucoma patients.
Goldman Sachs Recommends These 3 Growth Stocks As Strong Buys in September
Goldman Sachs identifies three compelling growth stocks worth considering, signaling a shift towards diverse sectors amidst a technology market rotation.
BioMarin continues wave of California biotech layoffs with 128 more cuts
BioMarin Pharmaceutical is laying off 225 employees as part of an organizational redesign due to financial pressures from gene therapy projects.
New Gene Delivery Method Paves the Way for Advanced Brain Therapies
AAVs have potential for gene therapy but struggle to cross the blood-brain barrier, complicating treatments for brain disorders.
How Do You Get Drugs to the Brain? Maybe Try a Parasite
Toxoplasma engineered to deliver proteins may offer treatment for brain disorders like Rett syndrome and neurodegenerative diseases.
Gene therapy has been successful in treating angiodema, a genetic disorder that causes painful swelling attacks.
The single-dose gene therapy using Crispr-Cas9 showed potential as a permanent cure for angiodema and has the potential to be a treatment for other genetic conditions.
Argentinian couple moves to US to allow their toddler to join gene therapy trial
Parents refused to give up despite rare disease diagnosis, traveled for gene therapy trial, showing hope and perseverance.
Gene therapy has been successful in treating angiodema, a genetic disorder that causes painful swelling attacks.
The single-dose gene therapy using Crispr-Cas9 showed potential as a permanent cure for angiodema and has the potential to be a treatment for other genetic conditions.
Gene therapy trial restores hearing in both ears for deaf children
Gene therapy trial restores hearing in deaf children, showing promise for future treatments.
Deaf baby hears for the first time after 'groundbreaking' gene therapy trial
Opal Sandy, born deaf due to a genetic condition, can now hear unaided after groundbreaking gene therapy.
Great Ormond Street hoping to license gene therapy for bubble baby' syndrome
Gene therapy trial had high success but was dropped by pharmaceutical company, prompting Great Ormond Street hospital to license the therapy non-profit for wider access.
UK toddler has hearing restored in world first gene therapy trial
Significant milestone in gene therapy for treating deafness.
Gene therapy hailed as medical magic wand' for hereditary swelling disorder
A groundbreaking gene therapy has provided a permanent cure for patients with hereditary angioedema, a rare and debilitating disease.
Patients in the first human trial of the therapy experienced a dramatic improvement in their symptoms and were able to come off long-term medication.
Gene therapy trial restores hearing in both ears for deaf children
Gene therapy trial restores hearing in deaf children, showing promise for future treatments.
Deaf baby hears for the first time after 'groundbreaking' gene therapy trial
Opal Sandy, born deaf due to a genetic condition, can now hear unaided after groundbreaking gene therapy.
Great Ormond Street hoping to license gene therapy for bubble baby' syndrome
Gene therapy trial had high success but was dropped by pharmaceutical company, prompting Great Ormond Street hospital to license the therapy non-profit for wider access.
UK toddler has hearing restored in world first gene therapy trial
Significant milestone in gene therapy for treating deafness.
Gene therapy hailed as medical magic wand' for hereditary swelling disorder
A groundbreaking gene therapy has provided a permanent cure for patients with hereditary angioedema, a rare and debilitating disease.
Patients in the first human trial of the therapy experienced a dramatic improvement in their symptoms and were able to come off long-term medication.
Breakthrough therapies at Stanford are saving lives. Can we afford them?
Cell and gene therapies offer promising medical solutions but come with a hefty price tag, raising concerns about availability and affordability.
Young Patient Dies After Receiving Pfizer Gene Therapy
The tragic death of a young boy during a Pfizer medical trial for Duchenne muscular dystrophy has raised concerns and questions among scientists and parents.
Gene therapy trials treat inherited blindness and deafness DW 05/09/2024
The article highlights the groundbreaking achievement of restoring hearing and vision through gene therapy in children with rare genetic mutations.
Stealthy stem cells to treat disease
Researchers can create specialized cell types from stem cells to treat diseases.
Immune-edited stem cells, via gene therapy like CRISPR-Cas, could lead to mass-produced cell therapies without immune suppression.
Vertex's CRISPR Gene Therapy Lands Another FDA Nod in a Rare Blood Disease
Vertex Pharmaceuticals and CRISPR Therapeutics' gene therapy, Casgevy, has received FDA approval as a treatment for beta thalassemia.
The therapy provides a one-time treatment option for transfusion-dependent beta thalassemia patients age 12 and older.
Daily briefing: 'Open-washing' plagues big AI
Open-source AI not as transparent as claimed
Low-frequency vibrations trigger mouse sexual behaviors
Importance of research putting individuals at the heart of schizophrenia study